Atherosclerosis and the antiphospholipid syndrome: A link unravelled?

Lupus

Volumn 7, Issue SUPPL. 2, 1998, Pages

  Shoenfeld, Yehuda ^a   Harats, D ^a,b   George, J ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antiphospholipid antibodies; Atherosclerosis; Autoimmunity; Lymphocytes; 2 glycoprotein I

Indexed keywords

BETA2 GLYCOPROTEIN 1; HEAT SHOCK PROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPHOSPHOLIPID SYNDROME; ARTERY; ATHEROSCLEROSIS; AUTOIMMUNITY; CONFERENCE PAPER; DISEASE COURSE; HUMAN; HUMORAL IMMUNITY; HYPERCOAGULABILITY; IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOSIS;

EID: 0031790329     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339800700231     Document Type: Conference Paper

References (29)

1. Ross R The pathogenesis of atherosclerosis a perspective for the 1990s. Nature 1993; 362: 801-809.
2. Steinberg D et al. Beyond cholesterol, modification of low density lipoprotein that increases its atherogenicity. N Engl J Med 1989; 320: 915-924.
3. Witztum JL. The oxidation hypothesis of atherosclerosis Lancet 1994; 344 793-795.
4. Wick G et al. Is atherosclerosis an immunologically mediated disease? Immunol Today 1995; 16 27-33.
5. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 1991; 64: 5-11
6. Cook PJ. Lip GYH Infectious agents and atherosclerotic vascular disease Q J Med 1996; 89 727-735.
7. Asherson RA, Cervera R, Piette JC, Shoenfeld Y (eds). The Annphospholipid Syndrome CRC Press: Boca Raton, FL, 1997.
8. 2GPI (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4124
9. 2-glycoprotein in the absence of phospholipids. Importance of antigen density and bivalent binding. J Immunol 1995; 154. 954-960.
10. Tsakraklidesm VG, Blieden IC, Edwards JE Coronary atherosclerosis and myocardial infarction associated with systemic lupus erythematosus. Am Heart J 1974; 87: 637-641.
11. Jonsson H, Nived O, Sturfelt O. Outcome of systemic lupus erythematosus, a prospective study of patients from a defined population. Medicine (Baltimore) 1989, 68: 141-150
12. Luliano L et al. Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies. Blood 1997; 90 3931-3935.
13. Ferro D et al. Coexistence of anti-phospholipid antibodies and endothelial perturbation in systemic lupus erythermatosus patients with ongoing prothrombotic state. Circulation 1997; 95. 1425-1432.
14. Vaarala O et al. Anti-cardiolipin antibodies and the risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 1995; 91: 23-27.
15. Vaarala O et al. Crossreaction between antibodies to oxidized low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 1993; 2: 923-925.
16. Mizutani H et al. Monoclonal anticardiolipin autoantibodies established from the (New Zealand White × BXSB)F1 mouse model for antiphospholipid syndrome cross-react with oxidized low-density lipoprotein Arthritis Rheum 1995, 38: 1382-1388
17. Horkko S et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. J Clin Invest 1996; 98: 815-825.
18. Palinski W, Miller E, Witztum JL. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acid Sci USA 1995;92; 821-825.
19. George J et al Hyperimmunization of ApoE deficient mice with homologous oxLDL suppresses early atherogenesis. Atherosclerosis, 1998, 138 147-152.
20. George J et al Induction of early atherosclerosis in LDL receptor deficient mice by immunization with beta 2 glycoproetin I. Circulation (in press).
21. George J et al Atherosclerosis in LDL receptor knockout mice is accelerated by immunization with anticardiolipin antibodies. Lupus 1997; 6: 723-729
22. Simantov R et al Activation of cultured endothelial cells by antiphopholipid antibodies. J Clin Invest 1995; 96: 2211-2219.
23. Del Papa N et al. Endothelial cells as target for antiphospholipid antibodies. Arthritis Rheum 1997, 3: 551-561.
24. 2GPI antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation 1998; 97: 900-906.
25. 2 glycoprotein I and anticardiolipin antibodies in oxidatively modified low density lipoprotein uptake by macrophages. Clin Exp Immunol 1997; 107: 569-574.
26. Chong BH, Brighton TC, Chesterman CN. Antiphospholipid antibodies and platelets. Semin Thromb Hemost 1995; 21 76
27. Thiagarajan P, Tau JF. Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem 1990; 265 17420
28. Blank M et al. Immunization with anticardiolipin cofactor (beta-2 glycoprotein-1) induces antiphospholipid syndrome in naive mice. J Autoimmunity 1994; 7: 441-455.
29. Garcia CO et al. Induction of experimental antiphospholipid syndrome in PL/J mice following immunization with beta 2 glycoprotein I Am J Reprod Immunol 1997; 37: 118-124.